Public Company News

Yalla Group Limited to Report Third Quarter 2022 Financial Results on November 14, 2022 Eastern Time

DUBAI, UAE, Nov. 4, 2022 /PRNewswire/ -- Yalla Group Limited ("Yalla" or the "Company") (NYSE: YALA), the leading voice-centric social networking and entertainment platform in theMiddle East and North Africa (MENA), today announced that it will report its unaudited financial results for the third...

2022-11-04 18:00 3927

TuanChe and S-TECH Technology Establish Strategic Cooperation to Develop and Market New Energy Vehicles

BEIJING, Nov. 4, 2022 /PRNewswire/ -- TuanChe Limited ("TuanChe" or the "Company") (NASDAQ: TC), a leading integrated automotive marketplace in China, has recently signed a strategic cooperation agreement with Beijing S-TECH Technology ("S-TECH"). S-TECH is a research-based technology company, s...

2022-11-04 18:00 3721

Goodbaby International Holdings Limited Announces Revenue Performance for the Nine Months Ended 30 September 2022

HONG KONG, Nov. 4, 2022 /PRNewswire/ -- Goodbaby International Holdings Limited ("Goodbaby International" or the "Company", HKEX stock code: 1086, together with its subsidiaries, the "Group"), a leading global parenting products company, today announced its unaudited revenue performance for the n...

2022-11-04 17:18 4617

Weibo Corporation to Report Third Quarter 2022 Financial Results on November 17, 2022

BEIJING, Nov. 4, 2022 /PRNewswire/ -- Weibo Corporation (NASDAQ: WB and HKEX: 9898), a leading social media for people to create, share and discover content, will announce its unaudited financial results for the third quarter 2022 before the U.S. market opens onThursday, November 17, 2022. Follow...

2022-11-04 17:00 3650

DouYu International Holdings Limited to Report Third Quarter 2022 Financial Results on November 21, 2022

WUHAN, China, Nov. 4, 2022 /PRNewswire/ -- DouYu International Holdings Limited ("DouYu" or the "Company") (Nasdaq: DOYU), a leading game-centric live streaming platform in China and a pioneer in the eSports value chain, today announced that it plans to release its unaudited financial results for...

2022-11-04 16:00 2816

Akeso Completes Enrollment in Phase III Trial of PD-1/VEGF Bispecific Antibody (AK112) Combined with Chemotherapy in EGFR-TKI-resistant nsq-NSCLC

HONG KONG, Nov. 3, 2022 /PRNewswire/ -- Akeso, Biopharma (9926. HK) ("Akeso") announced the patient enrollment completion for the Phase III clinical trial of Ivonescimab (PD-1/VEGF bi-specific antibody, AK112) combined with chemotherapy for the treatment of EGFR-mutant locally advanced or metasta...

2022-11-04 08:57 2264

Kuke Music Announces Receipt of Non-compliance Letter Regarding ADS Trading Price from NYSE

BEIJING, Nov. 3, 2022 /PRNewswire/ -- Kuke Music Holding Limited ("Kuke" or the "Company") (NYSE: KUKE), a leading classical music service platform inChina, announced that it has received a letter from the New York Stock Exchange (the "NYSE") datedSeptember 29, notifying Kuke Music that it is not...

2022-11-04 04:32 2571

ASH 2022 | Ascentage Pharma to Present Initial Data of Bcl-2 Inhibitor Lisaftoclax (APG-2575) in Combination with BTK Inhibitors for the Treatment of R/R CLL/SLL, Including an ORR of 98%, in an Oral Report at the ASH Annual Meeting

SUZHOU, China, and ROCKVILLE, Md., Nov. 3, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the initial results from a global Phase II st...

2022-11-04 03:33 3323

ASH 2022 | Ascentage Pharma to Present Data of Olverembatinib (HQP1351) in Three Oral Reports, Including the First Dataset from the First US Study, at the ASH Annual Meeting

SUZHOU, China, and ROCKVILLE, Md., Nov. 3, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the updated results from three studies of ...

2022-11-04 03:32 2672

LiveHire Announced as a Member on Newly Launched AMS Verified

MIAMI, Nov. 3, 2022 /PRNewswire/ -- LiveHire, the globally-leading direct sourcing and total talent platform, announced its membership on the newly launched AMS Verified platform. LiveHire and AMS launched a strategic alliance in 2021 to expand their joint offering to enterprises inNorth America....

2022-11-03 23:03 3216

Tuya Demonstrated Solutions for Matter at the Media Conference For the Launch of Matter to Build an Open and Intelligent Ecosystem

NEW YORK, Nov. 3, 2022 /PRNewswire/ -- Tuya Smart (NYSE: TUYA, HKEX: 2391), a global IoT development platform service provider, was invited by the Connectivity Standards Alliance to participate in the Matter's Global Media Conference inAmsterdam on November 3, Central European Time (CET) to sh...

2022-11-03 22:15 2940

Gracell Biotechnologies to Present First Clinical Data of FasTCAR-T GC012F for Newly Diagnosed Multiple Myeloma at 64th American Society of Hematology Annual Meeting & Exposition

BCMA/CD19 dual-targeting FasTCAR-T GC012F demonstrated 100% ORR and 100% MRD negativity in the 13 patients treated SAN DIEGO, Calif., SUZHOU and SHANGHAI, China, Nov. 3, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharm...

2022-11-03 21:10 2823

I-Mab Announces Two Poster Presentations of CD47 Antibody Lemzoparlimab at ASH 2022

GAITHERSBURG, MD. and SHANGHAI, Nov. 3, 2022 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that two poster presentations featuring preclinical and ...

2022-11-03 21:01 3029

An Award-Filled Fall for Wondershare as a Leader in G2's Quarterly Report

Wondershare has been a leader in the G2Crowd report for 19 consecutive quarters. VANCOUVER, BC, Nov. 3, 2022 /PRNewswire/ -- Wondershare , the global creative software company, is honored to be recognized as a leader across four categories in the G2 Fall 2022 Report...

2022-11-03 21:00 2672

Yuyu Pharma attendance at European Pharmaceutical Conference

SEOUL, South Korea, Nov. 3, 2022 /PRNewswire/ -- Robert Yu, CEO of Yuyu Pharma, has been attending biopharmaceutical conferences held inGermany, BIO-Europe and CPHI. The purpose is to explore opportunities to expand into international markets, such as Europe. 

2022-11-03 21:00 3752

Antelope Enterprise Appoints New Board Directors

JINJIANG, China, Nov. 3, 2022 /PRNewswire/ -- Antelope Enterprise Holdings Limited (NASDAQ Capital Market: AEHL) ("Antelope Enterprise" or the "Company"), which engages in business management, information systems consulting, and online social commerce and live streaming, and is a manufacturer of ...

2022-11-03 20:00 2377

Zhongchao Inc.'s China Operating Entity, Chongqing Xinjiang Pharmaceutical Co., Ltd. Obtained Pharmaceutical Trade and Medical Device Operation Licenses, Ready to Enter Into Pharmaceuticals Circulation Market

SHANGHAI, Nov. 3, 2022 /PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced that one of theChina operating entities of which the Company cons...

2022-11-03 19:30 2499

Renren Declares Special Cash Distribution for Settlement Regarding Shareholder Derivative Litigation

PHOENIX, Nov. 3, 2022 /PRNewswire/ -- Renren Inc. (NYSE: RENN) ("Renren" or the "Company"), an operator of several US-based SaaS businesses, today announced that its board of directors declared a special cash distribution in connection with the settlement contemplated by the Stipulation of Settle...

2022-11-03 19:00 2410

Five New Drug Candidates Show Promise as Ainos Pursues Licensing Partners of its Low-dose Oral Interferon Formulation

The FDA gave positive feedback regarding filing a Biologics License Application (BLA) for Sjögren's syndrome following two Phase 3 studies Ainos is seeking out-licensing opportunities to accelerate the process of bringing five new drug candidates to Phase 3 trials and eventual commercialization ...

2022-11-03 19:00 2117

Canadian Solar Obtains European ECS and EPD Environmental Certifications for Its High-Efficiency Solar Modules

GUELPH, ON, Nov. 3, 2022 /PRNewswire/ -- Canadian Solar Inc . (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced that its majority-owned subsidiary CSI Solar Co., Ltd. ("CSI Solar") has recently obtainedFrance's Simplified Carbon Assessment ("Evalua...

2022-11-03 19:00 3122
1 ... 542543544545546547548 ... 763

Week's Top Stories